| mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype N Herranz, S Gallage, M Mellone, T Wuestefeld, S Klotz, CJ Hanley, ... Nature cell biology 17 (9), 1205-1217, 2015 | 721 | 2015 |
| Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer M Malehmir*, D Pfister*, S Gallage*, M Szydlowska*, D Inverso*, E Kotsiliti, ... Nature medicine 25 (4), 641-655, 2019 | 346 | 2019 |
| Cardiac glycosides are broad-spectrum senolytics A Guerrero, N Herranz, B Sun, V Wagner, S Gallage, R Guiho, K Wolter, ... Nature Metabolism 1 (11), 1074-1088, 2019 | 290 | 2019 |
| PTBP1-mediated alternative splicing regulates the inflammatory secretome and the pro-tumorigenic effects of senescent cells A Georgilis, S Klotz, CJ Hanley, N Herranz, B Weirich, B Morancho, ... Cancer Cell 34 (1), 85-102. e9, 2018 | 206 | 2018 |
| Neutrophils induce paracrine telomere dysfunction and senescence in ROS‐dependent manner A Lagnado, J Leslie, MH Ruchaud‐Sparagano, S Victorelli, P Hirsova, ... The EMBO journal 40 (9), e106048, 2021 | 151 | 2021 |
| A researcher’s guide to preclinical mouse NASH models S Gallage, JEB Avila, P Ramadori, E Focaccia, M Rahbari, A Ali, ... Nature Metabolism 4 (12), 1632-1649, 2022 | 97 | 2022 |
| CD8+ T cells induce cachexia during chronic viral infection H Baazim, M Schweiger, M Moschinger, H Xu, T Scherer, A Popa, ... Nature immunology 20 (6), 701-710, 2019 | 78 | 2019 |
| Mitochondrial dysfunction meets senescence S Gallage, J Gil Trends in biochemical sciences 41 (3), 207-209, 2016 | 62 | 2016 |
| Sublethal necroptosis signaling promotes inflammation and liver cancer M Vucur, A Ghallab, AT Schneider, A Adili, M Cheng, M Castoldi, ... Immunity 56 (7), 1578-1595. e8, 2023 | 48 | 2023 |
| Suppression of MTHFD2 in MCF-7 breast cancer cells increases glycolysis, dependency on exogenous glycine, and sensitivity to folate depletion C Koufaris*, S Gallage*, T Yang, CH Lau, GN Valbuena, HC Keun Journal of proteome research 15 (8), 2618-2625, 2016 | 48 | 2016 |
| The therapeutic landscape of hepatocellular carcinoma S Gallage, M García-Beccaria, M Szydlowska, M Rahbari, R Mohr, ... Med 2 (5), 505-552, 2021 | 35 | 2021 |
| Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancer S Revia, A Seretny, L Wendler, A Banito, C Eckert, K Breuer, ... Gut 71 (8), 1613-1628, 2022 | 31 | 2022 |
| Detection of senescence using machine learning algorithms based on nuclear features I Duran, J Pombo, B Sun, S Gallage, H Kudo, D McHugh, L Bousset, ... Nature Communications 15 (1), 1041, 2024 | 21 | 2024 |
| L-Selectin/CD62L Is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and Men HK Drescher, A Schippers, S Rosenhain, F Gremse, L Bongiovanni, ... Cells 9 (5), 1106, 2020 | 21 | 2020 |
| TORn about SASP regulation N Herranz, S Gallage, J Gil Cell Cycle 14 (24), 3771-3772, 2015 | 15 | 2015 |
| A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1 S Gallage, A Ali, JEB Avila, N Seymen, P Ramadori, V Joerke, L Zizmare, ... Cell Metabolism 36 (6), 1371-1393. e7, 2024 | 13 | 2024 |
| Intermittent fasting-the future treatment in nash patients? I Minciună, S Gallage, M Heikenwalder, S Zelber-Sagi, JF Dufour Hepatology, 2023 | 13 | 2023 |
| Spontaneous cholemia in C57BL/6 mice predisposes to liver cancer in NASH S Gallage, A Ali, JEB Avila, D Herebian, MM Karimi, EE Irvine, D McHugh, ... Cellular and molecular gastroenterology and hepatology 13 (3), 875-878, 2022 | 11 | 2022 |
| Aging Research-Methodological Issues C García-Peña, LM Gutiérrez-Robledo, MU Pérez-Zepeda Springer, 2018 | 11 | 2018 |
| When Soluble Fibers Meet Hepatocellular Carcinoma: The Dark Side of Fermentation S Gallage, E Kotsiliti, M Heikenwalder Cell metabolism 28 (5), 673-675, 2018 | 8 | 2018 |
Mathias HeikenwälderUniv. Prof. at Department Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ))Verified email at dkfz.de
